AI Terminal
Primary Health Properties PLC
Director's Dealing • Feb 26, 2024
4780_dirs_2024-02-26_3b16614e-f897-4c04-b8cd-37fbe931ef03.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 4315E
Primary Health Properties PLC
26 February 2024
Primary Health Properties PLC
Director shareholding
The Company has been advised that the following information relating to the transaction below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation
| 1 | Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA") | ||
| (a) | Name | Harry Hyman | |
| 2 | Reason for the notification | ||
| (a) | Position/status | Chief Executive Officer | |
| (b) | Initial notification/ amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| (a) | Name of Entity | Primary Health Properties PLC | |
| (b) | Legal Entity Identifier | 213800Y5CJHXOATK7X11 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
| (a) | Description of the financial instrument | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 |
|
| (b) | Nature of the transaction | Purchase by ISA in dividend re-investment plan | |
| (c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.907 | 3,543 | ||
| (d) | Aggregated information Aggregated volume price |
Single transaction £3,214.04 |
|
| (e) | Date of transaction | 23 February 2024 | |
| (f) | Place of transaction | London Stock Exchange (xlon) |
For further information:
Primary Health Properties PLC
Toby Newman, Company Secretary
+44(0) 7729 047 959
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUNOWRSNUUURR